33.10 (1.77%) Sun Pharmaceutical Industries has informed that it enclosed a Press Release relating to licensing agreement between Sun Pharma and Pharmazz Inc. for introducing Tyvalzi™ (Sovateltide) in India.
The above information is a part of company’s filings submitted to BSE.